4.6 Article

Distinct Chemokine Receptor Axes Regulate Th9 Cell Trafficking to Allergic and Autoimmune Inflammatory Sites

期刊

JOURNAL OF IMMUNOLOGY
卷 191, 期 3, 页码 1110-1117

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1203089

关键词

-

资金

  1. National Health and Medical Research Council
  2. Multiple Sclerosis Research Australia
  3. National Institutes of Health [R01 AI37113]
  4. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Migration of Th cells to peripheral sites of inflammation is essential for execution of their effector function. The recently described Th9 subset characteristically produces IL-9 and has been implicated in both allergy and autoimmunity. Despite this, the migratory properties of Th9 cells remain enigmatic. In this study, we examined chemokine receptor usage by Th9 cells and demonstrate, in models of allergy and autoimmunity, that these cells express functional CCR3, CCR6, and CXCR3, chemokine receptors commonly associated with other, functionally opposed effector Th subsets. Most Th9 cells that express CCR3 also express CXCR3 and CCR6, and expression of these receptors appears to account for the recruitment of Th9 cells to disparate inflammatory sites. During allergic inflammation, Th9 cells use CCR3 and CCR6, but not CXCR3, to home to the peritoneal cavity, whereas Th9 homing to the CNS during experimental autoimmune encephalomyelitis involves CXCR3 and CCR6 but not CCR3. To our knowledge, these data provide the first insights into regulation of Th9 cell trafficking in allergy and autoimmunity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Microbiology

Dietary zinc and the control of Streptococcus pneumoniae infection

Bart A. Eijkelkamp, Jacqueline R. Morey, Stephanie L. Neville, Aimee Tan, Victoria G. Pederick, Nerida Cole, Prashina P. Singh, Cheryl-Lynn Y. Ong, Raquel Gonzalez de Vega, David Clases, Bliss A. Cunningham, Catherine E. Hughes, Iain Comerford, Erin B. Brazel, Jonathan J. Whittall, Charles D. Plumptre, Shaun R. McColl, James C. Paton, Alastair G. McEwan, Philip A. Doble, Christopher A. Mcdevitt

PLOS PATHOGENS (2019)

Article Immunology

ACKR4 restrains antitumor immunity by regulating CCL21

Carly E. Whyte, Maleika Osman, Ervin E. Kara, Caitlin Abbott, Jade Foeng, Duncan R. McKenzie, Kevin A. Fenix, Yuka Harata-Lee, Kerrie L. Foyle, Sarah T. Boyle, Marina Kochetkova, Amelia Roman Aguilera, Jiajie Hou, Xian-Yang Li, Mark A. Armstrong, Stephen M. Pederson, Iain Comerford, Mark J. Smyth, Shaun R. McColl

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Letter Otorhinolaryngology

Association between viral infection and increased mucosal eosinophils and CD8+CD103+ T cells in chronic rhinosinusitis

Rachel K. Goggin, Catherine A. Bennett, Mahnaz Ramezanpour, Hua Hu, Kevin Fenix, Ahmed Bassiouni, Shari Javadiyan, Seweryn Bialasiewicz, Peter-John Wormald, Alkis J. Psaltis, Sarah Vreugde

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2020)

Article Biochemistry & Molecular Biology

Immunological Memory in Imiquimod-Induced Murine Model of Psoriasiform Dermatitis

Kevin Fenix, Danushka K. Wijesundara, Allison J. Cowin, Branka Grubor-Bauk, Zlatko Kopecki

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Multidisciplinary Sciences

Scavenging of soluble and immobilized CCL21 by ACKR4 regulates peripheral dendritic cell emigration

Cameron R. Bastow, Mark D. Bunting, Ervin E. Kara, Duncan R. McKenzie, Adriana Caon, Sapna Devi, Lynn Tolley, Scott N. Mueller, Ian H. Frazer, Natasha Harvey, Mark R. Condina, Clifford Young, Peter Hoffmann, Shaun R. McColl, Iain Comerford

Summary: This study reveals the mechanism by which ACKR4 controls DC migration in barrier tissues, identifying the existence of two forms of CCL21 in steady-state conditions and their regulation by ACKR4. It enhances understanding of functional chemokine gradient formation by showing how ACKR4 affects CCL21 gradients in barrier tissues and downstream lymph nodes.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Nutrition & Dietetics

Combining the Anticancer and Immunomodulatory Effects of Astragalus and Shiitake as an Integrated Therapeutic Approach

Biju Balakrishnan, Qi Liang, Kevin Fenix, Bunu Tamang, Ehud Hauben, Linlin Ma, Wei Zhang

Summary: The study reviewed the anticancer and immunomodulating properties of Astragalus root and Shiitake mushrooms, and assessed the potential of developing medicinal food by transferring Astragalus polysaccharides into edible Shiitake with increased therapeutic potential through a novel manufacturing process. Further research efforts are needed to validate the therapeutic potential of this new Hengshan Astragalus Shiitake medicinal food.

NUTRIENTS (2021)

Article Immunology

CXCR5+CD8+ T Cells Shape Antibody Responses In Vivo Following Protein Immunisation and Peripheral Viral Infection

Timona S. S. Tyllis, Kevin A. A. Fenix, Todd S. S. Norton, Ervin E. E. Kara, Duncan R. R. McKenzie, Shannon C. C. David, Mohammed Alsharifi, Di Yu, Shaun R. R. McColl, Iain Comerford

Summary: The interaction between T and B cells is crucial for high-affinity antibody responses, with CD8(+) T cells playing a role in regulating antibody responses. A novel population of effector CD8(+) T cells has been identified, showing characteristics of Tfh cells and impacting B cell responses in protein immunisation and peripheral viral infection models, promoting class switching to IgG2c in responding B cells.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing

Bimala Dhakal, Celine Man Ying Li, Runhao Li, Kenny Yeo, Josephine A. Wright, Krystyna A. Gieniec, Laura Vrbanac, Tarik Sammour, Matthew Lawrence, Michelle Thomas, Mark Lewis, Joanne Perry, Daniel L. Worthley, Susan L. Woods, Paul Drew, Benedetta C. Sallustio, Eric Smith, John D. Horowitz, Guy J. Maddern, Giovanni Licari, Kevin Fenix

Summary: Cancer cells have altered metabolism to support their activities, and Perhexiline, a cardiovascular drug, can inhibit these changes and kill colorectal cancer cells. This drug has been used clinically and has the potential for repurposing in colorectal cancer management.

CANCERS (2022)

Article Biology

Characterization of human nasal organoids from chronic rhinosinusitis patients

Mahnaz Ramezanpour, Harrison Bolt, Karen Hon, Gohar Shaghayegh, Hadi Rastin, Kevin Aaron Fenix, James Psaltis Alkis, Peter -John Wormald, Sarah Vreugde

Summary: This study investigates the characteristics and cellular morphology of organoids derived from primary human nasal epithelial cells (HNECs) of chronic rhinosinusitis (CRS) patients. The results showed that nasal organoids expressed stem cell markers and markers for ciliated cells, and could regrow and expand well after freezing and thawing. This study provides an effective and feasible method for the development of human nasal organoids suitable for phenotypic high-throughput screening and drug response research.

BIOLOGY OPEN (2022)

Article Immunology

Characterising Distinct Migratory Profiles of Infiltrating T-Cell Subsets in Human Glioblastoma

Paris M. M. Kollis, Lisa M. M. Ebert, John Toubia, Cameron R. R. Bastow, Rebecca J. J. Ormsby, Santosh I. I. Poonnoose, Sakthi Lenin, Melinda N. N. Tea, Stuart M. M. Pitson, Guillermo A. A. Gomez, Michael P. P. Brown, Tessa Gargett

Summary: This study characterized the chemokine receptor and integrin expression profiles of endogenous glioblastoma-infiltrating T cells and identified potential homing receptor-ligand pairs that could enhance the tumour-homing properties of future T-cell immunotherapies for glioblastoma.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

TFR Cells Express Functional CCR6 But It Is Dispensable for Their Development and Localization During Splenic Humoral Immune Responses

Cameron R. Bastow, Ervin E. Kara, Timona S. Tyllis, Carola G. Vinuesa, Shaun R. McColl, Iain Comerford

Summary: Follicular T cells, including T follicular helper (T-FH) and T follicular regulatory (T-FR) cells, play essential roles in supporting and regulating antibody responses. This study found that follicular T cells express not only CXCR5 and CXCR4, but also CCR6, CCR2 and CXCR3. CCR6 is particularly highly expressed in T-FR cells and gating on CCR6(+)CXCR5(hi)PD-1(hi) T cells enriches for T-FR cells. However, CCR6 is not essential for development of the germinal center response and does not affect T-FR cell development and localization during splenic humoral responses.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Staphylococcus aureus biofilm properties and chronic rhinosinusitis severity scores correlate positively with total CD4+T-cell frequencies and inversely with its Th1, Th17 and regulatory cell frequencies

Gohar Shaghayegh, Clare Cooksley, George Bouras, Roshan Nepal, Ghais Houtak, Beula Subashini Panchatcharam, Kevin Aaron Fenix, Alkis James Psaltis, Peter-John Wormald, Sarah Vreugde

Summary: Chronic rhinosinusitis (CRS) is a chronic inflammation of the sinus mucosa characterized by dysfunction of the sinuses' defense mechanisms and induction of different inflammatory pathways. The presence of Staphylococcus aureus (S. aureus) in the sinonasal mucosa is associated with CRS, but it is also observed in healthy individuals, which challenges its significance in CRS pathogenesis. This study investigated the relationship between CRS inflammatory markers, S. aureus biofilm properties/virulence genes, and disease severity.

IMMUNOLOGY (2023)

Review Biochemistry & Molecular Biology

Perhexiline: Old Drug, New Tricks? A Summary of Its Anti-Cancer Effects

Bimala Dhakal, Yoko Tomita, Paul Drew, Timothy Price, Guy Maddern, Eric Smith, Kevin Fenix

Summary: Cancer metabolic plasticity, particularly fatty acid metabolism, plays a crucial role in cancer cell growth and malignancy. The drug perhexiline, which inhibits mitochondrial enzymes involved in fatty acid metabolism, has shown promising anti-cancer properties both as a monotherapy and in combination with traditional chemotherapeutics. This review explores the mechanisms of perhexiline's anti-cancer activities, including both CPT1/2 dependent and independent pathways, and discusses its potential as an anti-cancer agent, limitations, and ability to reduce cardiotoxicity induced by other chemotherapeutics.

MOLECULES (2023)

Article Immunology

Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation

Bimala Dhakal, Celine Man Ying Li, Mahnaz Ramezanpour, Ghais Houtak, Runhao Li, George Bouras, Alex Collela, Nusha Chegeni, Tim Kennion Chataway, Paul Drew, Benedetta C. Sallustio, Sarah Vreugde, Eric Smith, Guy Maddern, Giovanni Licari, Kevin Fenix

Summary: This study investigated the effect of Perhexiline (PHX) treatment on macrophage activation and polarization. The results showed that PHX promoted M1 macrophage polarization and led to changes in metabolic and immune signaling pathways.

FRONTIERS IN IMMUNOLOGY (2023)

Review Oncology

Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis

Celine Man Ying Li, Yoko Tomita, Bimala Dhakal, Runhao Li, Jun Li, Paul Drew, Timothy Price, Eric Smith, Guy J. Maddern, Kevin Aaron Fenix

Summary: This review systematically assessed the efficacy of cytokine-induced killer cell (CIK) therapy for colorectal cancer (CRC) treatment and found that CIK therapy improved overall survival, progression-free survival, and overall response rate without increasing toxicity. Further investigation into CIK therapy for CRC treatment is warranted.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

暂无数据